Germline mutations and polymorphisms in the origins of cancers in women.

Journal of Oncology
Kim M HirshfieldArnold J Levine

Abstract

Several female malignancies including breast, ovarian, and endometrial cancers can be characterized based on known somatic and germline mutations. Initiation and propagation of tumors reflect underlying genomic alterations such as mutations, polymorphisms, and copy number variations found in genes of multiple cellular pathways. The contributions of any single genetic variation or mutation in a population depend on its frequency and penetrance as well as tissue-specific functionality. Genome wide association studies, fluorescence in situ hybridization, comparative genomic hybridization, and candidate gene studies have enumerated genetic contributors to cancers in women. These include p53, BRCA1, BRCA2, STK11, PTEN, CHEK2, ATM, BRIP1, PALB2, FGFR2, TGFB1, MDM2, MDM4 as well as several other chromosomal loci. Based on the heterogeneity within a specific tumor type, a combination of genomic alterations defines the cancer subtype, biologic behavior, and in some cases, response to therapeutics. Consideration of tumor heterogeneity is therefore important in the critical analysis of gene associations in cancer.

References

Jan 16, 1999·Molecular and Cellular Biology·M ThomasG Matlashewski
Jun 8, 2000·Journal of the National Cancer Institute·I U Ali
Jun 23, 2000·British Journal of Cancer·A ChompretJ Feunteun
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T SørlieA L Børresen-Dale
Feb 5, 2003·Nature Genetics·Patrick DumontMaureen Murphy
Mar 6, 2003·Human Mutation·John M Parant, Guillermina Lozano
Jul 17, 2003·British Journal of Cancer·W LimR S Houlston
Jan 8, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Judy E Garber, Kenneth Offit
Mar 1, 2005·Experimental Gerontology·Diana van HeemstUNKNOWN Long Life study group
May 12, 2005·The Journal of Biological Chemistry·Lea M StaritaNatsuko Chiba
Feb 8, 2006·Oncogene·M Siddique, K Sabapathy
Feb 16, 2006·Journal of the National Cancer Institute·Chiara MeninRoberta Bertorelle
Feb 24, 2006·International Journal of Cancer. Journal International Du Cancer·Helge LindAage Haugen
May 3, 2006·Human Mutation·Denise L StredrickAlice J Sigurdson
Jul 11, 2006·Journal of Medical Genetics·Gareth L BondArnold J Levine
Sep 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Naoki OhmiyaHidemi Goto
Sep 26, 2006·Oncogene·A C Antoniou, D F Easton
Sep 26, 2006·Oncogene·H Nevanlinna, J Bartek
Sep 28, 2006·European Journal of Human Genetics : EJHG·Mariëlle W G RuijsLaura J Van't Veer
Jan 4, 2007·Nature Genetics·Nazneen RahmanMichael R Stratton
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Gurinder Singh AtwalRonit Yarden
Mar 21, 2007·PLoS Genetics·Paul D P PharoahUNKNOWN SEARCH Investigators
May 2, 2007·International Journal of Cancer. Journal International Du Cancer·Miina OllikainenPäivi Peltomäki
May 29, 2007·Molecular and Cellular Biology·Tamara TerzianGuillermina Lozano
May 29, 2007·Nature·Douglas F EastonBruce A J Ponder
Jun 5, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marta Sanchez-CarbayoCarlos Cordon-Cardo
Sep 7, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K HemminkiJ L Bermejo
Sep 11, 2007·Carcinogenesis·Stefan WilkeningKari Hemminki
Oct 9, 2007·Proceedings of the National Academy of Sciences of the United States of America·Zhaohui FengArnold J Levine
Oct 13, 2007·Science·Laura D WoodBert Vogelstein
Oct 25, 2007·International Journal of Cancer. Journal International Du Cancer·Geoffrey LiuDavid C Christiani
Nov 27, 2007·Breast Cancer Research : BCR·Silje H NordgardVessela N Kristensen
Nov 30, 2007·Nature·Wenwei HuArnold J Levine

❮ Previous
Next ❯

Citations

Jun 22, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Michael H RohChristopher P Crum
Jan 31, 2014·Breast Cancer Research and Treatment·Martin P NilssonNiklas Loman
Feb 1, 2011·Drug Delivery and Translational Research·Blanka SharmaVinod Labhasetwar
Mar 3, 2011·Familial Cancer·Erin W HofstatterNadine Tung
May 20, 2015·European Journal of Pharmacology·Anukriti SinghBushra Ateeq
Apr 25, 2015·The EPMA Journal·Godfrey GrechDominic M Desiderio
Jun 14, 2012·BMC Cancer·Amanda Gonçalves SilvaAna C V Krepischi
May 6, 2014·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Chandrababu Rejeeth, Soundrapandian Kannan
Jan 23, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Weiwei ShanXiaojun Chen
Feb 9, 2012·Breast Cancer Research : BCR·Ana Cv KrepischiCarla Rosenberg
Jul 12, 2019·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Alix BoomsSteven E Pierce

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.